Reports 11.5% YoY B2B ARR Increase and ARR of $22.5 Million
HENDERSON, Nev., Nov. 16, 2026 /PRNewswire/ — Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its first quarter ended September 30, 2026.
Fiscal First Quarter 2027 Summary (compared to prior-year quarter)
B2B ARR grew $1.7 million or 11.5% compared to the first quarter of fiscal 2026 resulting in $16.5 million of ARR. This included AI related ARR of $1.1 million which grew 38% sequentially from the fourth quarter of fiscal 2026.Platform revenue up 3.7% to $5.3 million. Annual Recurring Revenue (“ARR”) up 5.7% to $22.5 million, which includes approximately $16.5 million of B2B recurring revenue and $6.0 million of B2C recurring revenue.Total revenue of $11.9 million, compared to $12.3 million.Gross profit of $6.4 million compared to $6.2 million. Total gross margin improved 300 basis points to 53.6%, driven mainly by the continued platform mix shift and improved transaction margins.Net income of $765,000, or $0.02 per diluted share, compared to $749,000 or $0.02 per diluted share. Adjusted net income after excluding one-time items was $1.2 million or $0.04 per diluted share.Adjusted EBITDA of $1.0 million and an adjusted EBITDA margin of 8.6%. Adjusted EBITDA after excluding one-time items was $1.5 million.Cash flow from operations of $1.2 million compared to $1.1 million in the prior year. The Company ended the quarter with $12.6 million in cash and cash equivalents after paying $1.2 million of the Scite earn-out.
“Our continued investment in innovation is expanding how researchers discover, access, and engage with scientific literature,” said Roy W. Olivier, President and CEO of Research Solutions. “Recent launches of Article Galaxy and Scite integrations with ChatGPT, Claude, and Microsoft Copilot bring our capabilities directly into the AI-powered workflows researchers increasingly rely on, making it easier to find trusted evidence and access scholarly content. Platform revenue accounted for 45% of total revenue this quarter, up from 42% a year ago, reflecting our continued transition toward a higher-margin, recurring revenue model. This evolution is strengthening profitability and operating cash flow, enabling us to reinvest in sales capacity and product innovation to accelerate long-term growth.”
Fiscal First Quarter 2027 Results
Total revenue was $11.9 million, compared to $12.3 million in the year-ago quarter, as increased platform revenue was more than offset by a decrease in transaction revenue.
Platform subscription revenue for the quarter was $5.3 million, compared to $5.1 million in the prior-year period. The increase of 11.5% in B2B platform ARR was due to a mix of new logo generation and upsell and cross-sell into existing customers, partially offset by a decline in B2C revenue. The quarter ended with annual recurring revenue of $22.5 million, up 5.7% year-over-year (see the Company’s definition of annual recurring revenue below).
Transaction revenue was $6.6 million, compared to $7.2 million in the first quarter of fiscal 2026. The decrease was due to lower paid order volume. The transaction active customer count for the quarter was 1,360, compared to 1,326 customers in the prior-year quarter (see the Company’s definition of active customer accounts and transactions below).
Total gross margin improved 300 basis points from the prior-year quarter to 53.6%. The increase was primarily driven by the continued revenue mix shift to the higher-margin platforms business and an improvement in transactions gross margin to 26.7% from 23.8%, partially offset by a lower Platforms gross margin on slightly higher hosting and technology costs.
Total operating expenses were $5.5 million, compared to $5.3 million in the first quarter of 2026. The increase was primarily related to higher general and administrative expenses, driven by legal and severance costs along with higher technology and product development expense, partially offset by lower sales and marketing expense and a non-cash recovery of stock-based compensation due to restricted stock forfeitures.
Other expense for the quarter was approximately $0.1 million compared to $0.2 million in the first quarter of fiscal 2026, primarily due to lower accreted interest expense on the Scite earn-out liability.
Net income in the first quarter was $765,000 or $0.02 per diluted share, compared to $749,000, or $0.02 per diluted share, in the prior-year quarter. Adjusted EBITDA was $1.0 million, compared to $1.5 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).
Conference Call
Research Solutions President and CEO Roy W. Olivier and CFO David Kutil will host the conference call, followed by a question-and-answer period.
Date: Tuesday, November 17, 2026
Time: 9:00 a.m. ET (6:00 a.m. PT)
Dial-in number: 1-203-518-9765
Conference ID: RESEARCH
The conference call will be broadcast live and available for replay until December 17, 2026 by dialing 1-412-317-6671 and using the replay ID 11160802, and via the investor relations section of the Company’s website at http://researchsolutions.investorroom.com/.
Fiscal First Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
Quarter Ended September 30,
2026
2025
Change
% Change
Revenue:
Platforms
$ 5,309,780
$ 5,120,840
$ 188,940
3.7 %
Transactions
6,601,733
7,191,345
(589,612)
-8.2 %
Total Revenue
11,911,513
12,312,185
(400,672)
-3.3 %
Gross Profit:
Platforms
4,621,522
4,510,465
111,057
2.5 %
Transactions
1,759,458
1,714,833
44,625
2.6 %
Total Gross Profit
6,380,980
6,225,298
155,682
2.5 %
Gross profit as a % of revenue:
Platforms
87.0 %
88.1 %
-1.0 %
Transactions
26.7 %
23.8 %
2.8 %
Total Gross Profit
53.6 %
50.6 %
3.0 %
Operating Expenses:
Sales and marketing
1,463,197
1,666,825
(203,628)
-12.2 %
Technology and product development
1,665,892
1,410,151
255,741
18.1 %
General and administrative
2,225,243
1,675,359
549,884
32.8 %
Depreciation and amortization
310,863
316,066
(5,203)
-1.6 %
Stock-based compensation
(196,549)
212,482
(409,031)
-192.5 %
Foreign currency translation loss (gain)
(8,541)
(17,256)
8,715
-50.5 %
Total Operating Expenses
5,460,105
5,263,627
196,478
3.7 %
Income (loss) from operations
920,875
961,671
(40,796)
-4.2 %
Other Income (Expenses):
Other income (expenses)
(55,604)
(191,053)
135,449
NM
Provision for income taxes
(100,019)
(21,231)
(78,788)
371.1 %
Total Other Income (Expenses):
(155,623)
(212,284)
56,661
NM
Net income (loss)
$ 765,252
$ 749,387
15,865
2.1 %
Adjusted EBITDA
$ 1,026,648
$ 1,472,963
$ (446,315)
-30.3 %
Quarter Ended September 30,
2026
2025
Change
% Change
Platforms:
B2B ARR (Annual recurring revenue):
Beginning of Period
$ 16,202,626
$ 14,197,598
$ 2,005,028
14.1 %
Incremental ARR
$ 257,415
560,874
(303,459)
-54.1 %
End of Period
$ 16,460,041
$ 14,758,472
$ 1,701,569
11.5 %
Deployments:
Beginning of Period
1,276
1,171
105
9.0 %
Incremental Deployments
22
14
8
57.1 %
End of Period
1,298
1,185
113
9.5 %
ASP (Average sales price):
Beginning of Period
$ 12,698
$ 12,124
$ 574
4.7 %
End of Period
$ 12,681
$ 12,454
$ 227
1.8 %
B2C ARR (Annual recurring revenue):
Beginning of Period
$ 6,342,350
$ 6,721,356
$ (379,006)
-5.6 %
Incremental ARR
(298,571)
(186,159)
(112,412)
NM
End of Period
$ 6,043,779
$ 6,535,197
$ (491,418)
-7.5 %
Total ARR (Annualized recurring revenue):
$ 22,503,820
$ 21,293,669
$ 1,210,151
5.7 %
Transaction Customers:
Corporate customers
981
1,002
(21)
-2.1 %
Academic customers
379
324
55
17.0 %
Total customers
1,360
1,326
34
2.6 %
Active Customer Accounts, Transactions and Annual Recurring Revenue
The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The Company defines annual recurring revenue (“ARR”) as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the Company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company’s operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
Quarter Ended September 30,
2026
2025
Change
% Change
Net Income (loss)
$ 765,252
$ 749,387
$ 15,865
2.1 %
Add (deduct):
Other (income) expense
55,604
191,053
(135,449)
-70.9 %
Foreign currency translation loss (gain)
(8,541)
(17,256)
8,715
-50.5 %
Provision for income taxes
100,019
21,231
78,788
371.1 %
Depreciation and amortization
310,863
316,066
(5,203)
-1.6 %
Stock-based compensation
(196,549)
212,482
(409,031)
-192.5 %
Adjusted EBITDA
$ 1,026,648
$ 1,472,963
$ (446,315)
-30.3 %
About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com
Important Cautions Regarding Forward-Looking Statements
Certain statements in this press release may contain “forward-looking statements” regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as “expects,” “anticipates,” “targets,” “goals,” “projects”, “intends,” “plans,” “believes,” “seeks,” “estimates,” “endeavors,” “strives,” “may,” or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company’s most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company’s filings with the Securities and Exchange Commission.
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
September 30,
June 30,
2026
2026
Assets
Current assets:
Cash and cash equivalents
$
12,586,878
$
12,630,283
Accounts receivable, net of allowance of $89,077 and $103,217, respectively
6,649,615
6,963,040
Prepaid expenses and other current assets
633,216
689,548
Prepaid royalties
883,531
411,297
Total current assets
20,753,240
20,694,168
Non-current assets:
Property and equipment, net of accumulated depreciation of $1,026,480
and $1,020,241, respectively
62,906
58,671
Intangible assets, net of accumulated amortization of $4,245,965 and $3,947,231,
respectively
8,239,136
8,537,870
Goodwill
16,372,979
16,372,979
Deposits and other assets
996
1,030
Total assets
$
45,429,257
$
45,664,718
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses
$
7,075,360
$
6,149,480
Deferred revenue, current portion
10,796,348
11,467,832
Contingent earnout liability
5,561,906
7,323,314
Total current liabilities
23,433,614
24,940,626
Non-current liabilities:
Deferred revenue, long-term portion
7,157
17,245
Total liabilities
23,440,771
24,957,871
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued
and outstanding
—
—
Common stock; $0.001 par value; 100,000,000 shares authorized; 33,553,819 and
33,513,551 shares issued and outstanding, respectively
33,553
33,513
Additional paid-in capital
43,518,443
42,998,357
Accumulated deficit
(21,456,373)
(22,221,625)
Accumulated other comprehensive loss
(107,137)
(103,398)
Total stockholders’ equity
21,988,486
20,706,847
Total liabilities and stockholders’ equity
$
45,429,257
$
45,664,718
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income
(Unaudited)
Three Months Ended
September 30,
2026
2025
Revenue:
Platforms
$
5,309,780
$
5,120,840
Transactions
6,601,733
7,191,345
Total revenue
11,911,513
12,312,185
Cost of revenue:
Platforms
688,258
610,375
Transactions
4,842,275
5,476,512
Total cost of revenue
5,530,533
6,086,887
Gross profit
6,380,980
6,225,298
Operating expenses:
Selling, general and administrative
5,149,242
4,947,561
Depreciation and amortization
310,863
316,066
Total operating expenses
5,460,105
5,263,627
Income from operations
920,875
961,671
Other income
93,608
126,913
Accreted interest expense
(149,212)
(317,966)
Income before provision for income taxes
865,271
770,618
Provision for income taxes
(100,019)
(21,231)
Net income
765,252
749,387
Other comprehensive income (loss):
Foreign currency translation
(3,739)
967
Comprehensive income
$
761,513
$
750,354
Basic income per common share:
Net income per share
$
0.02
$
0.02
Weighted average common shares outstanding
32,644,399
31,234,875
Diluted income per common share:
Net income per share
$
0.02
$
0.02
Weighted average common shares outstanding
32,916,413
32,070,121
Research Solutions, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended
September 30,
2026
2025
Cash flow from operating activities:
Net income
$
765,252
$
749,387
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
310,863
316,066
Stock options expense
90,556
58,706
Restricted common stock expense (recovery due to forfeitures)
(287,105)
153,776
Accreted interest expense
149,212
317,966
Changes in operating assets and liabilities:
Accounts receivable
313,425
292,053
Prepaid expenses and other current assets
56,332
(140,004)
Prepaid royalties
(472,234)
(79,513)
Accounts payable and accrued expenses
925,880
158,728
Deferred revenue
(681,572)
(720,046)
Net cash provided by operating activities
1,170,609
1,107,119
Cash flow from investing activities:
Purchase of property and equipment
(17,050)
(17,539)
Net cash used in investing activities
(17,050)
(17,539)
Cash flow from financing activities:
Common stock repurchase
(10,039)
(23,387)
Payment of contingent acquisition consideration – Scite and FIZ
(1,183,906)
(1,337,857)
Net cash used in financing activities
(1,193,945)
(1,361,244)
Effect of exchange rate changes
(3,019)
115
Net decrease in cash and cash equivalents
(43,405)
(271,549)
Cash and cash equivalents, beginning of period
12,630,283
12,227,312
Cash and cash equivalents, end of period
$
12,586,878
$
11,955,763
Supplemental disclosures of cash flow information:
Cash paid for income taxes
$
21,261
$
21,231
Non-cash investing and financing activities:
Contingent consideration accrual on asset acquisition
$
—
$
29,117
Common stock issued for Scite earnout payment
$
726,714
$
726,714
View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-first-quarter-fiscal-year-2027-results-302940963.html
SOURCE Research Solutions, Inc.